Seelos Therapeutics (SEEL) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

SEEL is expected to report earnings to fall 98.79% to -7 cents per share on November 29

Seelos Therapeutics SEEL Stock Earnings Reports

Q3'23

Est.

$-0.08

Q2'23

Missed

by $6.51

Q1'23

Missed

by $0.01

Q4'22

Missed

by $4.93

Q3'22

Est.

$-0.18

The last earnings report on August 11 showed earnings per share of -659 cents, missing the estimate of -9 cents. With 1.33M shares outstanding, the current market capitalization sits at 1.70M.

View a ticker or compare two or three

Compare

SEEL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For SEEL
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of novel therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

300 Park Avenue

Phone

+1 646 293-2100

Employees

Web

https://www.seelostherapeutics.com